Optic Nerve Sheath Diameter as a Screening Test for Increased Intracranial Pressure
- Conditions
- Coma
- First Posted Date
- 2015-01-14
- Last Posted Date
- 2015-06-16
- Target Recruit Count
- 100
- Registration Number
- NCT02338284
- Locations
- 🇸🇦
King Faisal Specialist Hospital & Research Centre, Riyadh, Ar-Riyadh, Saudi Arabia
Algorithm for Oliguria in Septic Shock
- Conditions
- Acute Kidney Injury
- First Posted Date
- 2015-01-14
- Last Posted Date
- 2015-01-26
- Target Recruit Count
- 40
- Registration Number
- NCT02338895
- Locations
- 🇸🇦
King Faisal specialist Hospital & Research Center, Riyadh, Ar Riyadh, Saudi Arabia
Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)
Phase 4
Completed
- Conditions
- Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition
- Interventions
- Drug: Glargine InsulinDrug: Regular insulin
- First Posted Date
- 2014-08-15
- Last Posted Date
- 2016-02-25
- Target Recruit Count
- 61
- Registration Number
- NCT02216799
- Locations
- 🇸🇦
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial
Not Applicable
Terminated
- Conditions
- Infant, Very Low Birth Weight
- Interventions
- First Posted Date
- 2013-02-27
- Last Posted Date
- 2024-03-06
- Target Recruit Count
- 220
- Registration Number
- NCT01799629
- Locations
- 🇸🇦
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
🇸🇦Security Forces Hospital, Riyadh, Saudi Arabia
🇸🇦Sulaiman Al habib Medical Center, Riyadh, Saudi Arabia
Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer
Phase 2
Terminated
- Conditions
- Carcinoma of Esophagus
- Interventions
- Drug: Cisplatin, fluorouracil and concurrent radiation therapy
- First Posted Date
- 2012-05-31
- Last Posted Date
- 2018-08-10
- Target Recruit Count
- 170
- Registration Number
- NCT01608464
- Locations
- 🇸🇦
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation
Phase 3
Completed
- Conditions
- Transplantation for Hematologic Malignancies
- First Posted Date
- 2012-02-10
- Last Posted Date
- 2018-08-10
- Target Recruit Count
- 230
- Registration Number
- NCT01530581
- Locations
- 🇸🇦
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Phase 3
Completed
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2012-02-10
- Last Posted Date
- 2016-02-25
- Target Recruit Count
- 416
- Registration Number
- NCT01530607
Lenalidomide and Low Dose Dexamethasone Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone for Induction, in Patients With Previously Untreated Multiple Myeloma
Phase 3
Completed
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2012-02-10
- Last Posted Date
- 2016-02-25
- Target Recruit Count
- 440
- Registration Number
- NCT01530594
- Locations
- 🇸🇦
King Faisal Specialist Hospital &Reseach Center, Riyadh, Saudi Arabia
Prospective Phase II Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline®, Genzyme) With Ciclosporin for Patients With Acquired Aplastic Anaemia
Phase 2
Completed
- Conditions
- Acquired Aplastic Anaemia
- Interventions
- First Posted Date
- 2012-02-10
- Last Posted Date
- 2016-02-25
- Target Recruit Count
- 35
- Registration Number
- NCT01530555
The Placebo Effect May Involve Modulating Drug Bioavailability
Not Applicable
Completed
- Conditions
- Placebo EffectDrug Half LifePharmacokinetics
- Interventions
- Drug: Caffeine, paracetamol, cephalexin, or ibuprofenDrug: Placebo (caffeine, paracetamol, cephalexin, or ibuprofen)
- First Posted Date
- 2011-12-29
- Last Posted Date
- 2013-04-09
- Target Recruit Count
- 162
- Registration Number
- NCT01501747
- Locations
- 🇸🇦
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia